Not too long ago, a second-year woman DNB resident doctor at Dr Baba Saheb Ambedkar Hospital, Rohini’s gynaecology department, was allegedly brutally attacked. This happened in broad daylight. The doctor was responsible for delivering a baby via caesarean section, and had informed that the baby had an Asphyxia score of three at birth, which meant the baby had a poor chance of survival. Despite seven days of ventilator support, the baby could not be saved. The consequence? The relatives allegedly attacked the doctor.

“Violence against doctors is not rare—it’s routine,” says Dr Dilip Bhanushali, National President, IMA. Rightly so, doctors have been facing violence at the hands of their patients and their families. “We’ve seen mobs arrive with kerosene, petrol, even swords, burning down hospitals. There was a law during COVID promising seven years imprisonment and non-bailable warrants for attacks on doctors, but it hasn’t been enforced. Most states still have weak three-year, bailable punishments,” points out Dr Bhanushali.

This is why this year’s theme for National Doctors’ Day is hard-hitting, but fits in perfectly with the ongoing scenarios.

National Doctor’s Day 2025 Theme

Behind The Mask: Who Heals The Healer?

Amid all the pressure and often walking on eggshells, how do doctors cope? This is something we have not thought about. This is why this year’s theme, Who Heals The Healer, is important. It compels us to think about the other side, the doctor’s side.

To answer how doctors cope, Dr Bhanushali says, “Doctors have been doing this for ages, they have been coping up, facing these hurdles. Still, they are doing their services. They sacrifice their lives.”

ALSO READ: Healers, But Human Too: The Quiet Burdens Our Doctors Carry

Honoring National Doctors Day 2025: Medical Heroes Who Never Give Up

“Doctors continue to run medical camps, offer charity treatment—up to 30% of our practice is free. We don’t want anything bad to happen to our patients. Our profession is to heal.”

This year’s theme thus works as a reflection on the mental and emotional toll that doctors and other healthcare professionals face. The theme also asks the society to recognize doctors not just as medical professionals, but as humans, who, too, need support.

National Doctor’s Day 2025: History and Significance

Why is the day observed? The intent is to honor and acknowledge doctors’ and medical staff’s contributions to society. Furthermore, the theme asks for empathy from people.

The origin of Doctor’s Day came in 1991, when it was observed for the first time. The Government of India declared July 1 as National Doctors’ Day in honor of Dr Bidhan Chandra Roy, who has shown compassion and laid the foundation of same for many doctors to come. Dr Roy was born on July 1 1882, and died on the same day in 1962. He was also the personal physician of Mahatma Gandhi, and dedicated his life to people, which earned him the Bharat Ratna.

ALSO READ: Why Is It Important To Observe A Day For Doctors?

Why 2025 National Doctor Day Theme Is So Important?

Not just the violence, points out Dr Bhanushali, but there are many other problems that doctors face. Mixopathy, he points out, is a “maniacal idea”. He says, “Training doctors for just one and a half years to perform 50 surgeries? That’s dangerous. Becoming a surgeon takes a decade of rigorous study. You can’t make a khichdi out of medical systems like Ayurveda, Allopathy, and Homoeopathy. Let each system stand on its own merit, not blur the lines for convenience."

He also pointed out that the government has only spent 1.9% of the country’s GDP on health, whereas “it should be at least 5%.”

“We produce over a lakh doctors annually. WHO recommends one doctor per 1,000 people. We’re at 1 per 850—but there’s no infrastructure, especially in rural areas. We are ready to serve there if the basics exist,” he notes. He further added that while schemes like Ayushman Bharat are promising, “the payments are delayed by months”. What he pointed out was that doctors are fighting a battle at almost every front, which is why it is important that people show compassion towards them.

The fight is not just for doctors and their rights alone; their fight is also for people. Dr Bhanushali pointed out that doctors have asked for HPV vaccination to be part of immunization programs and to be given for free to women aged 9 to 14. “Evidence clearly shows it helps prevent cervical cancer—the leading cancer among Indian women,” he points out.

The fight, too, is against the quacks, who have outnumbered qualified doctors. “Quackery is rampant. They prescribe high-end antibiotics and steroids irresponsibly. Telangana has made progress by identifying hundreds of them, but most get bail the same day. Without strict laws, this menace won’t stop,” he says.

In return for it all, what doctors ask for is support, which makes this year’s theme more important.

‘Don’t these issues frustrate the doctors?’ one might ask. While the answer to it is yes, they do. Dr Bhanushali, however, reminds doctors that “at the end of the day, we are here for the people.”

“Doctors keep going, even after everything. During COVID, so many doctors died. Still, we didn’t stop. And we won’t. My message to fellow doctors is: don’t lose your empathy and sympathy. Keep serving.”

Jesy Nelson, former Little Mix singer, 34, and her fiancé, Zion Foster welcomed their twins, Ocean Jade and Story Monroe Nelson-Foster were devastated when the doctors broke the news that "they are probably never going to be able to walk, they probably will never regain their neck strength, so they will be disabled". Both the twins were diagnosed with SMA-1, a rare disease, known as the spinal muscular atrophy type 1.

Zion, 27, shared a poem for his eight-month-old warrior little girls. The Sun reported, he said: "They said it’s unlikely you’ll walk, you may not be able to talk, probably won’t be able to hold your head up, that’s what me and Jesy heard – SMA Type 1.

And it became so clear, doctors only go near what they can measure, so what’s certain?

I watch your smiles like sunsets, not promised, but real. I listen to you babble the sweetest melodies, in the moment it makes me wonder, if I keep telling you who I want you to be, what I want you to do, what I expect from you, am I loving you, or am I loving my fear?

If I take you for how God knitted you, just as you are, nothing removed, am I loving you? Am I accepting you?

Story, is your heart okay? Ocean, how’s your mind? I hear strength in your lungs every time you cry, two little warrior girls who already know how to fight.

Honestly, my worry isn’t the milestones, isn’t forcing life to live a different way. My worry is quieter than that, deeper. It’s about accepting you, loving you for who you are right now, without conditions.

No matter what tomorrow brings, and no matter what yesterday was."

What Treatment Jesy Nelson's Daughter Are Undergoing?

Jesy said, "They have had their treatment, thank God. A one-off infusion. That puts the gene back in their body that they don't have. It stops the muscles still working from dying. Any that have gone you can't regain them back."

While she does not reveal the name of the treatment, it is a single dose gene treatment, where patients receive an intravenous adeno-associated virus stereotype 9 carrying SMN complementary DNA encoding the missing SMN protein, as mentions a 2017 study published in The New England Journal of Medicine, or the Zolgensma, a prescribed gene therapy used to treat children less than 2 years old with SMA.

“Now it’s down to constant physio. We’ve been told they’ll probably never walk or regain their neck strength. They’ll probably be in wheelchairs.”

Also Read: Former Little Mix singer Jesy Nelson's Twin Babies Have SMA-1; Signs She Is Asking Other Parents To Look Out For

Jesy Nelson Twins: What Is SMA-1?

SMA-1. a rare disease, known as the spinal muscular atrophy type 1 or the Werdnig-Hoffmann disease is when the muscle weakness appears at birth or within the first six months. This rare condition prevents infants from sitting unassisted and causing severe breathing, swallowing, and sucking difficulties, leading to a poor prognosis without aggressive support. This condition has impacted the twin babies of the former Little Mix singer Jesy Nelson. Her twin babies may never be able to walk. However, she said that her babies will "fight all the odds" after they were being diagnosed with such a rare genetic condition.

Nelson said that there could be some common signs to look out for, which includes floppiness, inability to hold yourself up without support, a "frog-like" positioning of the legs without much movement, and rapid breathing in the tummy.

"If anyone is watching this video and they think they see these signs in their child, then please, please take your child to the doctor, to the hospital, because time is of the essence, and your child will need treatment. And the quicker you get this, the better their life will be," she added.

Flu cases are starting to fall, yet experts caution that the United States still faces risks. In the week ending January 10, fifteen more children died from the flu, bringing the total pediatric deaths this season to 32, as per NBC News.

Flu Season: Latest CDC Data

On Friday, the Centers for Disease Control and Prevention (CDC) reported an 18% drop in confirmed flu cases compared with the previous week. Visits to doctors for respiratory illnesses decreased by more than 5%, and hospitalization rates fell by nearly 55%. Influenza-related deaths, however, rose by 2%.

So far this flu season, the CDC estimates that 18 million people have been infected, including 230,000 hospitalizations and 9,300 deaths.

“It seems like there is some cautious good news that cases are declining,” said Jennifer Nuzzo, director of the Pandemic Center at Brown University School of Public Health. “But I’m going to put a giant asterisk on this because that does not mean the worst is behind us.”

Last year, flu cases dipped around this time before climbing again in early February.

Flu Season: State-by-State Variation

CDC data reflect a national trend, but not all states have necessarily reached their peak. “We are not going to all experience this at the same time,” said Beth Carlton, a public health professor at the University of Colorado, as per NBC News. “Nationwide, the trend is downward, but different states and communities may see spikes as the virus spreads.”

Flu often appears first in densely populated areas like New York City before moving to rural regions, but the virus can behave unpredictably.

Flu Season: Impact on Schools

Although flu cases may be falling overall, other winter illnesses such as norovirus, Covid, and strep throat are still causing school closures in states including Arkansas, Kansas, Kentucky, Tennessee, and West Virginia.

High flu activity continues in Idaho, New Mexico, New York, and parts of Appalachia, while Montana, South Dakota, Vermont, and Wyoming report lower case numbers.

“The number of people hospitalized for influenza around New Year’s was extremely high—the second highest in the past decade, with last year being the highest,” Carlton said.

Flu Season: A Difficult Flu Season

This year’s severe flu season is driven by a heavily mutated strain of influenza A called H3N2 subclade K. Its mutations make it less similar to the strain used in this year’s vaccine. Influenza-like illnesses, including RSV and Covid, are also unusually high, Nuzzo said.

“Typically these viruses peak at different times, but this year they are peaking together, making the season particularly harsh,” she noted.

While there were concerns that the vaccine would be less effective against subclade K, recent research shows the current flu shot still offers protection, particularly against hospitalization. The vaccine covers three strains: H1N1, H3N2, and one B strain.

Flu Season: Pediatric Risk

As per NBC News, last year marked the deadliest flu season for children since the CDC began tracking pediatric deaths, with 289 children dying—more than during the 2009 H1N1 pandemic.

“That double peak last season clearly had consequences,” Nuzzo said. “Any decline this season is welcome, but we can’t assume the worst is over.”

Among children eligible for the flu shot whose vaccination status was known, 90% of pediatric deaths occurred in unvaccinated kids.

Following recent CDC guidance, flu shots are no longer recommended for all children, a change from the previous advice that everyone six months and older should be vaccinated annually.

The Saudi Arabian Food and Drug Authority has cleared Anktiva, an IL-15–based immunotherapy created by billionaire physician-scientist Patrick Soon-Shiong and his biotech firm ImmunityBio, for the treatment of bladder cancer and lung cancer. This marks the first time the therapy has received national regulatory approval outside the United States.

The move signals an important global step for Anktiva, which currently holds a limited approval from the U.S. Food and Drug Administration. In the U.S., the drug is authorised only for patients with BCG-unresponsive, non–muscle-invasive bladder cancer (NMIBC) that includes carcinoma in situ. American regulators have so far resisted expanding its use to other bladder cancer subtypes. Saudi regulators, however, have adopted a broader stance, approving Anktiva for two cancer types under their domestic regulatory system.

What Is Anktiva?

Anktiva is an interleukin-15 receptor agonist designed to stimulate the body’s own immune defences. It works by activating and expanding natural killer (NK) cells and memory CD8⁺ T cells, which play a key role in immune surveillance. Unlike chemotherapy or gene-based treatments, Anktiva does not attack tumour cells directly. Instead, it boosts existing immune pathways to help the body recognise and destroy cancer cells.

ImmunityBio describes Anktiva as “the first FDA-approved immunotherapy that activates what’s called a natural killer cell to target and kill non-muscle-invasive bladder cancer cells.” In clinical practice, the drug is used alongside BCG (Bacillus Calmette-Guérin) in patients whose NMIBC has not responded to BCG alone. It is administered directly into the bladder through a catheter, followed by a structured maintenance schedule

Clinical Evidence Supporting FDA Approval in NMIBC

The FDA’s approval, issued on April 22, 2024, was based on results from a single-arm clinical study involving 77 patients with BCG-unresponsive stage 0 NMIBC. Participants received intravesical Anktiva combined with BCG, with maintenance therapy continuing for as long as 37 months.

The main efficacy results were as follows:

• Complete response rate: 62%

Durability:

• 58% of patients who responded remained disease-free for at least 12 months
• 40% stayed disease-free for 24 months or longer

For patients facing the prospect of radical cystectomy as the only curative option, these results were considered clinically significant. Still, the absence of a randomised control group has remained a point of contention among regulators and experts.

Regulatory Tension in the United States

Although the FDA approved Anktiva for NMIBC cases involving carcinoma in situ, it declined to extend the indication to patients with papillary-only disease. ImmunityBio pushed back against the decision, arguing that the same clinical data had already been deemed sufficient to support approval in a closely related patient group.

Rachel Sherman, MD, former principal deputy commissioner of the FDA, publicly criticised the agency’s stance, saying: “it is incomprehensible to me that the FDA refuses to file a supplemental BLA, stating the study is not sufficient to support a regulatory review, when it has already approved a product based on that very same study in essentially the same indication and population.”

The FDA has also expressed concerns about how the drug has been marketed. It issued a warning letter to ImmunityBio over promotional materials that cited survival benefits and cystectomy-avoidance rates not supported by robust evidence.

Saudi regulators, by contrast, have taken a more permissive view, approving Anktiva for both bladder and lung cancer and highlighting a willingness to act in areas of high unmet medical need.

With this decision, Saudi Arabia becomes the first country to approve Anktiva beyond NMIBC, potentially placing itself at the forefront of evaluating the therapy’s wider role across multiple cancer types.